Takahashi J, Kinomura S, Abe Y, Yoshioka S, Yambe T, Ono S, Ito H, Fukuda H, Yamada K, Sato T
Dept. of Nuclear Medicine and Radiology, Tohoku University.
Gan To Kagaku Ryoho. 1994 Dec;21(16):2817-20.
We encountered two cases of malignant effusion treated successfully by loco-regional administration of carboplatin (CBDCA). One case was a 60-year-old male showing recurrent non-small cell lung cancer (adenocarcinoma) with pericarditis carcinomatosa. A drainage from the pericardial cavity was performed and a total dose of 600 mg (single dose, 300 mg) of CBDCA was administered into the cavity. Malignant effusion disappeared and radiographic improvement was also observed. No pericardial effusion was observed for about 4 months after the loco-regional treatment, till he died of lung cancer. Another case was a 58-year-old male having invasive thymoma (mixed cell type) with pleuritis carcinomatosa. He received palliative radiation therapy and systemic cancer chemotherapy concurrently. As a loco-regional therapy, drainage from the pleural cavity was performed, and 300 mg of CBDCA and 10 KE of OK-432 were administered into the cavity. A remarkable reduction of pleural effusion was observed after the therapy. No increase of pleural effusion has been observed radiographically for about 18 months, and the patient is still alive with the tumor. The side effects due to loco-regional administration of CBDCA were quite tolerable in both cases.
我们遇到了两例通过局部注射卡铂(CBDCA)成功治疗的恶性积液病例。一例是一名60岁男性,患有复发性非小细胞肺癌(腺癌)并伴有癌性心包炎。进行了心包腔引流,并向腔内注射了600毫克(单次剂量300毫克)的卡铂。恶性积液消失,影像学检查也有改善。局部治疗后约4个月未观察到心包积液,直至他死于肺癌。另一例是一名58岁男性,患有浸润性胸腺瘤(混合细胞型)并伴有癌性胸膜炎。他同时接受了姑息性放射治疗和全身癌症化疗。作为局部治疗,进行了胸腔引流,并向腔内注射了300毫克卡铂和10KE的OK-432。治疗后观察到胸腔积液明显减少。影像学检查约18个月未观察到胸腔积液增加,该患者仍带瘤存活。两例中局部注射卡铂引起的副作用均相当耐受。